North America Medical Oxygen Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
North America Medical Oxygen Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
North America Medical Oxygen Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| North America Medical Oxygen Total | $ 883.48 Million | $ 1153.22 Million | $ 1965.68 Million | 6.893% |
| United States | $ 684.7 Million | $ 889.12 Million | $ 1505.67 Million | 6.806% |
| Canada | $ 128.99 Million | $ 171.84 Million | $ 300.79 Million | 7.249% |
| Mexico | $ 69.8 Million | $ 92.26 Million | $ 159.22 Million | 7.059% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Form breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Medical Oxygen Market
Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.
Medical Oxygen industry news
In February 2024, Intel announced the official launch of Altera, its new standalone FPGA company. During the FPGA Vision Webcast, Chief Executive Officer Sandra Rivera and Chief Operating Officer Shannon Poulin unveiled their strategy to secure leadership across a $55 billion-plus market opportunity, expand the company's portfolio, including the only FPGA with A.I. built into the fabric, and help solve mounting customer challenges. They also announced Altera as the new company's brand.
(Source: https://precisionmedical.com/supplements-and-home-remedies-to-help-relieve-sinus-infections/)
In January 2024, With the GA F.L.X., Atlas Copco introduced an entirely new rotary screw compressor type: the dual-speed compressor. It operates at two speeds, one for maximum capacity and a minimum speed, to reduce energy consumption during unloading. As a result, it is up to 20% more efficient than a traditional fixed-speed compressor.
(Source: https://www.atlascopco.com/en-in/compressors/air-compressor-blog/dual-speed-technolog/)
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Medical Oxygen Market size was estimated at USD 3154.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1261.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. In North America, Liquid oxygen emerged as the dominant segment in the medical oxygen market over the forecast period, holding the major market share. Liquid oxygen is favored for its high oxygen concentration and efficient storage and delivery capabilities. It is suitable for patients requiring high-flow oxygen therapy and healthcare facilities with high-demand requirements. The segment's dominance can be attributed to its advantages in terms of reliability, continuous supply, and convenience, particularly in critical care settings.
- According to Cognitive Market Research, the U.S. had a major share in the Medical Oxygen Market with a market size of USD 995.47 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. The country has a well-developed healthcare infrastructure with a high prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, which necessitate the use of medical oxygen therapy.
- The Canada Medical Oxygen Market had a market share of USD 151.40 million in 2024 and is projected to grow at a CAGR of 6.2% during the forecast period. As the population ages, the prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma is expected to increase, driving the demand for medical oxygen.
- The Mexico Medical Oxygen Market is projected to grow at a CAGR of 5.9% during the forecast period, reaching a market size of USD 114.81 million in 2024.
This section explores the key market dynamics for North America Medical Oxygen Market Analysis within the chemical industry. Our analysis details the primary drivers, restraints, opportunities, and the technological roadmap shaping the sector. We examine how factors like raw material availability, economic conditions, and stringent environmental and safety regulations impact the production, pricing, and distribution of chemicals. This intelligence helps businesses understand current market conditions and technological advancements, enabling informed strategic planning in a complex regulatory environment.
Analyst Conclusion
- Auther say's: North America held the major market of more than 40% of the global revenue with a market size of USD 1261.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
- The Liquid Oxygen segment is set to rise. Liquid oxygen is a convenient and efficient form of oxygen storage and delivery, particularly in healthcare settings where high volumes of oxygen are required.
- The rising incidence of respiratory conditions such as COPD, asthma, and pneumonia drives the demand for medical oxygen as a vital therapy for patients experiencing breathing difficulties.
Chidanand Bilagi is a Senior Research Associate at Cognitive Market Research and Consulting, specializing in the chemical and materials industry. With a strong focus on global chemical markets, advanced materials, specialty chemicals, sustainable materials, and emerging industrial innovations, he delivers in-depth market intelligence and strategic insights to support informed decision-making.
His expertise includes analyzing industry trends, competitive landscapes, supply chain dynamics, regulatory developments, raw material pricing patterns, and technological advancements shaping the future of the chemical and materials sector. Through rigorous research and data-driven analysis, Chidanand contributes to the development of comprehensive market reports, helping businesses, investors, and industry stakeholders identify opportunities and address challenges in an evolving global market landscape.
Frequently Asked Questions
★ Reviews
Rate this report
North America Medical Oxygen Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Form | Liquid Oxygen , Compressed , Oxygen Concentrators , Others |
|---|---|
| Application | COPD , Bronchopulmonary , Lung Disorder , Heart Failure , Asthma , Cystic Fibrosis , Others |
| End-User | Hospitals , Ambulatory Centres , Emergency Medical Centres , Homecare |
| Purity | 96% to 99.5% , 93% to 96% |
| Delivery | Aerial Diffusion , Direct Inhalation , Others |
| Modality | Portable Medical Oxygen Systems , Standalone Medical Oxygen Systems , Market Split by Technology , Continuous Flow , Pulse Dose |
| List of Competitors | Koninklijke Philips N.V, Inogen, B.O.C. Healthcare, Precision Medical, Luxfer Group, Cryofab, Responsive Respiratory, Atlas Copco, G.C.E. group, High Vacuum Maintenance (H.V.M.) S.R.L. |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 Koninklijke Philips N.V
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 Inogen
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 B.O.C. Healthcare
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Precision Medical
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Luxfer Group
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 Cryofab
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 Responsive Respiratory
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Atlas Copco
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 G.C.E. group
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.10 High Vacuum Maintenance (H.V.M.) S.R.L.
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 R&D Investment (Subject to data availability)
- 1.2.10.4 Financials (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
- 1.2.1 Koninklijke Philips N.V
- 1.1 Top Competitors Analysis
Chapter 2. Global Medical Oxygen Market Analysis
- 2.1 Global Medical Oxygen Market Analysis
- 2.2 Global Medical Oxygen Market Analysis by Region
- 2.3 Global Medical Oxygen Market Analysis by Form
- 2.4 Global Medical Oxygen Market Analysis by Application
- 2.5 Global Medical Oxygen Market Analysis by End-User
- 2.6 Global Medical Oxygen Market Analysis by Purity
- 2.7 Global Medical Oxygen Market Analysis by Delivery
- 2.8 Global Medical Oxygen Market Analysis by Modality
Chapter 3. North America Medical Oxygen Market Analysis
- 3.1 North America Medical Oxygen Market Analysis
- 3.2 North America Medical Oxygen Market Analysis by Country
- 3.3 North America Medical Oxygen Market Analysis by Form
- 3.4 North America Medical Oxygen Market Analysis by Application
- 3.5 North America Medical Oxygen Market Analysis by End-User
- 3.6 North America Medical Oxygen Market Analysis by Purity
- 3.7 North America Medical Oxygen Market Analysis by Delivery
- 3.8 North America Medical Oxygen Market Analysis by Modality
- 3.9 North America Medical Oxygen Market Analysis by Key Players
Chapter 4. United States Medical Oxygen Market Analysis
- 4.1 United States Medical Oxygen Market Analysis
- 4.2 United States Medical Oxygen Market Analysis by Form
- 4.3 United States Medical Oxygen Market Analysis by Application
- 4.4 United States Medical Oxygen Market Analysis by End-User
- 4.5 United States Medical Oxygen Market Analysis by Purity
- 4.6 United States Medical Oxygen Market Analysis by Delivery
- 4.7 United States Medical Oxygen Market Analysis by Modality
- 4.8 United States Medical Oxygen Market Analysis by Key Players
Chapter 5. Canada Medical Oxygen Market Analysis
- 5.1 Canada Medical Oxygen Market Analysis
- 5.2 Canada Medical Oxygen Market Analysis by Form
- 5.3 Canada Medical Oxygen Market Analysis by Application
- 5.4 Canada Medical Oxygen Market Analysis by End-User
- 5.5 Canada Medical Oxygen Market Analysis by Purity
- 5.6 Canada Medical Oxygen Market Analysis by Delivery
- 5.7 Canada Medical Oxygen Market Analysis by Modality
- 5.8 Canada Medical Oxygen Market Analysis by Key Players
Chapter 6. Mexico Medical Oxygen Market Analysis
- 6.1 Mexico Medical Oxygen Market Analysis
- 6.2 Mexico Medical Oxygen Market Analysis by Form
- 6.3 Mexico Medical Oxygen Market Analysis by Application
- 6.4 Mexico Medical Oxygen Market Analysis by End-User
- 6.5 Mexico Medical Oxygen Market Analysis by Purity
- 6.6 Mexico Medical Oxygen Market Analysis by Delivery
- 6.7 Mexico Medical Oxygen Market Analysis by Modality
- 6.8 Mexico Medical Oxygen Market Analysis by Key Players
Chapter 7. Form Analysis
- 7.1 Liquid Oxygen
- 7.2 Compressed
- 7.3 Oxygen Concentrators
- 7.4 Others
Chapter 8. Application Analysis
- 8.1 COPD
- 8.2 Bronchopulmonary
- 8.3 Lung Disorder
- 8.4 Heart Failure
- 8.5 Asthma
- 8.6 Cystic Fibrosis
- 8.7 Others
Chapter 9. End-User Analysis
- 9.1 Hospitals
- 9.2 Ambulatory Centres
- 9.3 Emergency Medical Centres
- 9.4 Homecare
Chapter 10. Purity Analysis
- 10.1 96% to 99.5%
- 10.2 93% to 96%
Chapter 11. Delivery Analysis
- 11.1 Aerial Diffusion
- 11.2 Direct Inhalation
- 11.3 Others
Chapter 12. Modality Analysis
- 12.1 Portable Medical Oxygen Systems
- 12.2 Standalone Medical Oxygen Systems
- 12.3 Market Split by Technology
- 12.4 Continuous Flow
- 12.5 Pulse Dose
Chapter 13. Qualitative Analysis (Subject to Data Availability)
- 13.1 Market Drivers
- 13.2 Market Restraints
- 13.3 Market Trends
- 13.4 Market Opportunity
- 13.5 Technological Road Map (Subject to Data Availability)
- 13.6 Product Life Cycle (Subject to Data Availability)
- 13.7 Customer and Buyer Behavior Analysis
- 13.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 13.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 13.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 13.7.4 Pricing, Affordability & Value Perception Analysis
- 13.7.5 Customer Segmentation & Demand Pattern Analysis
- 13.8 PESTEL Analysis
- 13.8.1 Environmental Factors
- 13.8.2 Legal Factors
- 13.8.3 Technological Factors
- 13.8.4 Economic Factors
- 13.8.5 Political Factors
- 13.8.6 Social Factors
- 13.9 Industrial Chain Analysis (Subject to Data Availability)
- 13.9.1 Industry Chain Analysis
- 13.9.2 Manufacturing Cost Analysis
- 13.9.3 Supply Side Analysis
- 13.9.3.1 Raw Material Analysis
- 13.9.3.2 Raw Material Procurement Analysis
- 13.9.3.3 Raw Material Price Trend Analysis
- 13.10 ESG Analysis
- 13.11 Patent Analysis (Subject to Data Availability)
- 13.12 Porter’s Five Forces Analysis
- 13.12.1 Bargaining Power of Suppliers
- 13.12.2 Degree of Competition
- 13.12.3 Threat of Substitutes
- 13.12.4 Threat of New Entrants
- 13.12.5 Bargaining Power of Buyers
- 13.13 Geopolitical Outlook
- 13.13.1 Global Power Realignment & Strategic Alliances
- 13.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 13.13.3 International Trade Relations & Market Access Environment
- 13.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 13.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 13.13.6 Technology Sovereignty & Digital Geopolitics
- 13.13.7 Strategic Implications for Investment, Growth & Market Entry
- 13.14 AI & Market Transformation
- 13.14.1 Competitive Landscape Disruption & Strategic Shifts
- 13.14.2 AI-Driven Transformation of Industry Value Chain
- 13.14.3 Evolution of Business Models & Revenue Streams
- 13.14.4 AI-Driven Product, Service & Innovation Transformation
- 13.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 14. Research Findings
- 14.1 Key Takeaways
- 14.2 Analyst Point of View
- 14.3 Assumptions and Acronyms
Chapter 15. Research Methodology and Sources
- 15.1 Primary Data Collection
- 15.1.1 Steps for Primary Data Collection
- 15.1.1.1 Identification of KOL
- 15.1.2 Backward Integration
- 15.1.3 Forward Integration
- 15.1.4 How Primary Research Help Us
- 15.1.5 Modes of Primary Research
- 15.1.1 Steps for Primary Data Collection
- 15.2 Secondary Research
- 15.2.1 How Secondary Research Help Us
- 15.2.2 Sources of Secondary Research
- 15.3 Data Validation
- 15.3.1 Data Triangulation
- 15.4 Data Representation
- 15.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Chidanand Bilagi and team for the North America Medical Oxygen Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Chemical & Materials Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the North America Medical Oxygen Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the north america medical oxygen market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report (250+ pages)
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
